Gardner Russo & Quinn’s Elevance Health ELV Stock Holding History

Gardner Russo & Quinn’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-100	Closed	-$23K	–	120
2017 Q4	$23K	Buy	+100	New	+$21.3K	﹤0.01%	173

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gardner Russo & Quinn's ELV Position: Q1 2018 in Review

Gardner Russo & Quinn sold out of Elevance Health (ELV) in Q1 2018, closing a stake of 100 shares — an estimated $23K sold.

Gardner Russo & Quinn first reported a position in ELV in Q4 2017 and held it in 1 quarter. The position peaked at $23K in Q4 2017. 922 funds tracked by Wall St. Rank hold ELV as of Q1 2018.

Gardner Russo & Quinn reported no remaining Elevance Health position as of Q1 2018 after selling out during the quarter.
Gardner Russo & Quinn sold 100 Elevance Health shares in Q1 2018, an estimated $23K.
Gardner Russo & Quinn first reported a position in Elevance Health in Q4 2017 and held it in 1 quarter.
Gardner Russo & Quinn's Elevance Health position peaked at $23K in Q4 2017.
922 funds tracked by Wall St. Rank held Elevance Health as of Q1 2018.

Based on Gardner Russo & Quinn's 13F filing for Q1 2018, filed 11 May 2018.